Results 291 to 300 of about 214,937 (381)

The Effect of Warm Compress Therapy on Reducing Gastritis Pain: A Literature Review

open access: diamond
Dewi Anggi Saputri   +3 more
openalex   +2 more sources

Tegoprazan‐Based Triple Therapy for Helicobacter pylori Eradication: A Phase III Multicenter Randomized Clinical Trial

open access: yesHelicobacter, Volume 31, Issue 1, January/February 2026.
ABSTRACT Background Tegoprazan, a potassium‐competitive acid blocker, offers potent and sustained acid inhibition and potentially improves eradication efficacy. Aim This study aimed to evaluate the efficacy and safety of tegoprazan‐based triple therapy with two dosing regimens compared with that of lansoprazole‐based therapy for first‐line Helicobacter
Jae Yong Park   +19 more
wiley   +1 more source

What shapes local alcohol, narcotics, and tobacco policy in Sweden?

open access: yesInternational Journal of Social Welfare, Volume 35, Issue 1, January 2026.
Abstract Swedish municipalities vary significantly in their commitment to preventing alcohol, narcotics, and tobacco related (ANT) problems. This study investigates the drivers of local policy development, focusing on the salience of ANT‐related problems, municipal economic resources, and the political orientation of local governments.
Thor Norström   +3 more
wiley   +1 more source

Protumorigenic Responses of CEACAM6 in Helicobacter pylori‐Infected Gastric Cancer Cells

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 2, January 2026.
ABSTRACT Helicobacter pylori poses a significant risk for gastric cancer (GC) development. H. pylori exploits carcinoembryonic antigen‐related cell adhesion molecules (CEACAMs) on GC cells (GCCs) to colonise the gastric epithelium. CEACAM1, CEACAM5 and CEACAM6 are known to interact with H. pylori. We explored the role of H.
Debashish Chakraborty   +12 more
wiley   +1 more source

Outcomes of Sequential Immune Checkpoint Inhibitor Retreatment After Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

open access: yesJournal of Gastroenterology and Hepatology, Volume 41, Issue 1, Page 302-311, January 2026.
ABSTRACT Background and Aim Data on sequential immune checkpoint inhibitor (ICI) retreatment following initial atezolizumab plus bevacizumab (Atez + Bev) are limited. This study aimed to evaluate the efficacy and safety of sequential ICI retreatment in patients with unresectable hepatocellular carcinoma (uHCC). Methods Of 835 patients with uHCC treated
Takanori Ito   +24 more
wiley   +1 more source

Exploring Clinical Similarities and Distinctions Between Gastroparesis and Functional Dyspepsia: A Propensity‐Matched Cohort Study

open access: yesNeurogastroenterology &Motility, Volume 38, Issue 1, January 2026.
Despite overlapping upper gastrointestinal symptoms, gastroparesis and functional dyspepsia demonstrate distinct population‐level symptom patterns, with nausea, vomiting, and bloating predominating in gastroparesis and epigastric pain in functional dyspepsia.
Sameer Rao   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy